{
  "context": {
    "rules": [
      "Rule1: If the electromagnetic interference test passed for device1, then market release is not authorized for device1.",
      "Rule2: Either the electromagnetic interference test passed for device1, or the temperature stability test passed for device1.",
      "Rule3: Provided that the temperature stability test passed for device1, the humidity resistance test passed for device1 follows.",
      "Rule4: Under the condition that the humidity resistance test passed for device1, the vibration test passed for device1.",
      "Rule5: Assuming the vibration test passed for device1, market release is not authorized for device1.",
      "Rule6: Should the power supply fail for device1, the battery backup is not activated for device1.",
      "Rule7: Given that the emergency shutdown protocol is active for device1, if the power supply fails for device1, then the battery backup is activated for device1.",
      "Rule8: If a software malfunction is detected in device1, then the emergency shutdown protocol becomes active for device1.",
      "Rule9: Provided that a hardware failure is detected in device1, the emergency shutdown protocol is active for device1.",
      "Rule10: On the condition that research for study1 is completed, the regulatory submission for device1 is filed.",
      "Rule11: Either research for study1 is completed, or the clinical trial passed for device1.",
      "Rule12: Whenever an adverse event is recorded for device1, patient harm is reported for device1.",
      "Rule13: In case the clinical study is successful for device1, FDA approval is granted for device1.",
      "Rule14: The clinical study is successful for device1, or real-world testing is completed for device1.",
      "Rule15: If real-world testing is completed for device1, then the field performance of device1 is verified.",
      "Rule16: In case special monitoring is approved for device1, post-market surveillance is required for device1.",
      "Rule17: Either special monitoring is approved for device1, or conditional approval is granted for device1.",
      "Rule18: Provided that conditional approval is granted for device1, should the regulatory audit pass for device1, then whenever real-world testing is completed for device1, FDA approval is granted for device1.",
      "Rule19: If the biocompatibility test passed for device1, then in the event that FDA approval is not granted for device1, device1 is not approved.",
      "Rule20: On the condition that material degradation is observed in device1, the structural integrity of device1 is not compromised.",
      "Rule21: If the clinical trial passed for device1, then assuming FDA approval is not granted for device1, device1 is not approved.",
      "Rule22: Given that the accelerated aging test is completed for device1, if material degradation is observed in device1, then the structural integrity of device1 is compromised.",
      "Rule23: Either the accelerated aging test is completed for device1, or shelf life validation is done for device1.",
      "Rule24: In case shelf life validation is done for device1, then should material degradation be observed in device1, the structural integrity of device1 is compromised.",
      "Rule25: If the risk assessment is updated for device1, then provided that it is not the case that either a software malfunction is detected in device1 or a hardware failure is detected in device1, a device recall is issued for device1.",
      "Rule26: Either the risk assessment is updated for device1, or the failure mode analysis is completed for device1.",
      "Rule27: Provided that the failure mode analysis is completed for device1, a preventive measure is established for device1.",
      "Rule28: Whenever the root cause is identified for device1, then on the condition that it is not the case that either a software malfunction is detected in device1 or a hardware failure is detected in device1, a device recall is issued for device1.",
      "Rule29: If a corrective action is implemented for device1, then the root cause for device1 is identified.",
      "Rule30: Given that a preventive measure is established for device1, a design change is approved for device1.",
      "Rule31: Assuming a design change is approved for device1, the manufacturing process is improved for device1.",
      "Rule32: Under the condition that the manufacturing process is improved for device1, a corrective action is implemented for device1.",
      "Rule33: If the performance standard for device1 is exceeded, then the performance benchmark for device1 is not met.",
      "Rule34: Should the validation protocol be executed for device1, the verification testing is completed for device1.",
      "Rule35: In case verification testing is completed for device1, then assuming it is not the case that field performance verification for device1 implies FDA approval for device1, the performance standard for device1 is exceeded.",
      "Rule36: If the user acceptance test passes for device1, then FDA approval is granted for device1.",
      "Rule37: Whenever clinical efficacy is demonstrated for device1, the user acceptance test passes for device1.",
      "Rule38: An alternative design for device1 is proposed, or if the regulatory submission is filed for device1, then in the event that FDA approval is not granted for device1, device1 is not approved.",
      "Rule39: If extended follow-up is approved for device1, then a long-term study is commenced for device1.",
      "Rule40: In case additional data collection is required for device1, then on the condition that post-market evaluation is initiated for device1, if real-world testing completion for device1 does not result in clinical efficacy demonstration for device1, the therapeutic benefit of device1 is questioned.",
      "Rule41: If a patient registry is established for device1, then a monitoring network is activated for device1.",
      "Rule42: Either a patient registry is established for device1, or an outcome database is created for device1.",
      "Rule43: Should an outcome database be created for device1, additional data collection is required for device1.",
      "Rule44: Under the condition that a monitoring network is activated for device1, extended follow-up is approved for device1.",
      "Rule45: Whenever a compliance certificate is issued for device1, then if real-world testing is completed for device1, FDA approval is granted for device1.",
      "Rule46: Legal protection is secured for device1, or if a competitor challenge is filed against device1, then a patent infringement claim is made against device1.",
      "Rule47: Either quality control passed for device1, or the safety test passed for device1.",
      "Rule48: Provided that the safety test passed for device1, a manufacturing defect is not detected in device1.",
      "Rule49: Market release is authorized for device1, or if quality control passed for device1, then a manufacturing defect is not detected in device1.",
      "Rule50: Should it not be the case that real-world testing completion for device1 implies clinical efficacy demonstration for device1, the therapeutic benefit of device1 is not questioned.",
      "Rule51: If it is not the case that regulatory audit passage for device1 results in compliance certificate issuance for device1, then a competitor challenge is filed against device1.",
      "Rule52: Given that it is not true that field performance verification for device1 leads to FDA approval for device1, the performance benchmark for device1 is met.",
      "Rule53: In the event that it is not true that the negation of either software malfunction detection or hardware failure detection in device1 results in a device recall for device1, an adverse event is recorded for device1.",
      "Rule54: If the biocompatibility test did not pass for device1, then material degradation is observed in device1.",
      "Rule55: Should FDA approval not be granted for device1, device1 is approved.",
      "Rule56: Provided that FDA approval is not granted for device1, the power supply for device1 fails.",
      "Rule57: Under the condition that FDA approval is not granted for device1, a manufacturing defect is detected in device1."
    ],
    "facts": [
      "Fact1: The regulatory audit for device1 passed.",
      "Fact2: The validation protocol for device1 is executed.",
      "Fact3: Post-market evaluation for device1 is initiated.",
      "Fact4: A device recall for device1 is not issued.",
      "Fact5: Patient harm related to device1 is not reported.",
      "Fact6: Post-market surveillance for device1 is not required.",
      "Fact7: A long-term study for device1 is not commenced.",
      "Fact8: An alternative design for device1 is not proposed.",
      "Fact9: A patent infringement claim against device1 is not made.",
      "Fact10: Legal protection for device1 is not secured."
    ]
  },
  "question": "FDA approval for device1 is granted."
}